Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Vanguard

Vanguard PRIMECAP Core Fund (VPCCX)

Ticker VPCCX · · Holdings as of Jun 30, 2026

Expense ratio
0.37%$37/yr per $10k
5-yr return
+14.6%annualized
1-yr return
+30.2%as of Dec 2025
Net assets
$18.1Ball share classes
Holdings
184

Bottom line

Is VPCCX a good fund? The bottom line

VPCCX is an actively managed large blend mutual fund from Vanguard.

It charges 0.37% — about $37 a year on every $10,000 invested, cheaper than 86% of large blend funds we track.

It returned +30.2% over one year, +14.6% a year over five years, +14.4% a year over ten (as of Dec 31, 2025, per its prospectus).

With $18.1 billion in net assets and 184 holdings, its largest position is Micron Technology Inc (9.1%) and the top 10 make up 41.2% of the portfolio.

What stands out

  • Low cost: cheaper than 86% of large blend peers
  • 5-year return beat 89% of category peers
  • No front-end sales load
  • Large and established ($18.1 billion)

Updated Nov 19, 2026

What VPCCX invests in

Vanguard PRIMECAP Core Fund (the Fund) seeks to provide long-term capital appreciation.

The Fund employs an active management approach, investing in stocks that its advisor believes offer a good balance between reasonable valuations and attractive growth prospects relative to their peers. Stocks selected for the Fund typically have earnings growth potential that, in the advisors view, is not reflected in their current market prices. The Fund can invest in stocks across all industry sectors and market capitalizations. The Fund may invest up to 25% of its assets in foreign securities, which may include depositary receipts. Foreign securities may be traded on U.S. or foreign markets.

From the fund's prospectus (filed Jan 28, 2026).

VPCCX performance

Fund calendar-year total returns, 2018–2025 2018: −4.9%; 2019: +27.7%; 2020: +12.1%; 2021: +24.4%; 2022: −12.4%; 2023: +23.5%; 2024: +12.9%; 2025: +30.2% −5% 2018 +28% 2019 +12% 2020 +24% 2021 −12% 2022 +24% 2023 +13% 2024 +30% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
VPCCX+30.2%+14.6%+14.4%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full VPCCX performance history →

What VPCCX costs

On a $10,000 investment, VPCCX's 0.37% expense ratio costs about $37 a year. The prospectus estimates $468 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full VPCCX fee table →

VPCCX top 10 holdings

#Holding% of fund
1Micron Technology Inc9.12%
2Intel Corp6.71%
3Eli Lilly & Co5.29%
4Flex Ltd5.27%
5KLA Corp3.29%
6Alphabet Inc2.73%
7Vanguard Cmt Funds-Vanguard Market Liquidity Fund2.68%
8AstraZeneca PLC2.50%
9Siemens AG1.81%
10Charles Schwab Corp/The1.76%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 41.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to VPCCX

More funds like VPCCX →

VPCCX FAQ

What is the expense ratio of VPCCX?
VPCCX's expense ratio is 0.37%, which works out to about $37 a year for every $10,000 invested. The prospectus estimates total costs of $468 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is VPCCX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 86% of large blend peers; 5-year return beat 89% of category peers; no front-end sales load; large and established ($18.1 billion). This is general information, not personalized advice.
What does VPCCX hold?
VPCCX's largest holdings are Micron Technology Inc (9.1%), Intel Corp (6.7%), Eli Lilly & Co (5.3%), Flex Ltd (5.3%), KLA Corp (3.3%). It holds 184 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is VPCCX's 5-year return?
VPCCX returned +14.6% a year over the five years ending Dec 31, 2025, and +14.4% a year over ten years. Past performance does not guarantee future results.
Does VPCCX have a sales load?
No. VPCCX has no front-end sales charge.
Who manages VPCCX?
VPCCX is offered by Vanguard through Vanguard Fenway Funds.